http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106119193-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1121 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1114 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0646 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783 |
| filingDate | 2016-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106119193-B |
| titleOfInvention | A kind of preparation method for the T cells with antigenic specificity having NK cell speciality concurrently |
| abstract | A kind of preparation method for the T cells with antigenic specificity having NK cell speciality concurrently.The IL-15 of given dose is added by co-culturing T cell with certain proportion with the antigen presenting cell for presenting specific antigen in the present invention, thus activation and rapid amplifying specific T-cells.Resulting T cell had both maintained the specific killing power to the tumour cell for presenting antigen in cell surface, while also having NK cell speciality concurrently, expressed CD56, has the very strong non-restrictive lethality of MHC, can effectively kill the tumour cell for not expressing MHC. |
| priorityDate | 2016-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.